Final analysis of the NEOMET trial of neoadjuvant metformin: Examining effects on Ki67, gene expression, and pathway analysis in primary operable breast cancer.
A. M. Thompson
No relevant relationships to disclose
T. Iwamoto
No relevant relationships to disclose
L. Jordan
No relevant relationships to disclose
C. Purdie
No relevant relationships to disclose
S. E. Bray
No relevant relationships to disclose
L. Baker
No relevant relationships to disclose
G. Hardie
No relevant relationships to disclose
L. Pusztai
No relevant relationships to disclose
S. L. Moulder
No relevant relationships to disclose
J. A. Dewar
No relevant relationships to disclose
S. M. Hadad
No relevant relationships to disclose